In March 2018, Costa Saroukos was appointed Takeda’s Chief Financial Officer. He is also a member of the Takeda Executive Team (TET) reporting to the company’s President & CEO and serves as a member of the company’s Board of Directors.
Mr. Saroukos has over 20 years’ experience in both the private and public sectors, having held a number of finance leadership positions with financial responsibility for businesses in over 100 countries across Asia-Pacific, Europe, Africa and the Middle East.
Mr. Saroukos has been with Takeda since May 2015, as Chief Financial Officer of the Europe and Canada Business Unit, significantly contributing to the transformation of the Business Unit towards a specialty healthcare provider.
Prior to joining Takeda, Mr. Saroukos was at Allergan as Head of Finance and Business Development for the Asia-Pacific region, including China and Japan. He was also Finance Director for Greater China and Japan. Previously, he spent 13 years at Merck & Co. in roles of increasing responsibility, including Executive Finance Director for EEMEA (Eastern Europe, Middle East and Africa), Finance Director of South Korea and Head of Internal Audit Asia Pacific and Global Joint Ventures.
Mr. Saroukos has a long track record of improving operational business profitability and driving performance by combining effective financial stewardship with business partnership. Throughout his career, he has promoted the use of best-practice sharing and talent development to build strong finance business and strategic partners.
Mr. Saroukos holds a Bachelor of Commerce majoring in Accounting and is a member of the Australian Society of Certified Practicing Accounts.